Sanofi SA (ADR) (NYSE:SNY) said the U.S. Food and Drug Administration had agreed to review Genzyme’s resubmission of its application for its Lemtrada drug for the treatment of relapsing forms of multiple sclerosis. Sanofi SA (ADR) (NYSE:SNY) stock opened today at $53.14 and is currently trading at $53.12. The stock showed a positive weekly performance of 0.49%.
As previously announced, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) are scheduled to present a corporate overview today at the Jefferies 2014 Global Healthcare Conference. The company recently initiated dosing in an investigational Phase 1b clinical trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1, or S1P1, receptor, to evaluate the compound for the treatment of a number of autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1b trial will evaluate the safety, tolerability and pharmacokinetics of multiple-ascending doses of APD334 in up to 96 healthy adult volunteers. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened at $6.08, in current trading session and currently is at $6.03, by losing -0.41%. The 52 week range of $4.05 – $9.05. Company’s market capitalization is 1.33 billion.
Cardinal Health (NYSE:CAH)‘s stock had its “overweight” rating reiterated by stock analysts at Morgan Stanley in a report issued on Monday. They currently have a $76.00 price objective on the stock. Morgan Stanley’s price objective would indicate a potential upside of 7.60% from the company’s current price. Cardinal Health Inc. (NYSE:CAH) stock is currently trading at $70.69. The EPS of the stock is 0.97. Company’s market capitalization is 24.05 billion.
Thermo Fisher Scientific Inc. (NYSE:TMO) the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Goldman Sachs 35th Annual Global Healthcare Conference on Tuesday, June 10, 2014, at 11:20 a.m. (PDT) at the Terranea Resort, Rancho Palos Verdes, Calif. Thermo Fisher Scientific Inc. (NYSE:TMO) stock opened the session at $116.00, and now is at $117.27. The 52 week range of the Thermo Fisher Scientific Inc. (NYSE:TMO) stock remained $81.04 – $127.63 and the day range was $115.97 – $117.48.
Henry Schein, Inc. (NASDAQ:HSIC) has acquired Sirona Direct, the France dental distribution business of Sirona Dental Systems, Inc. (NASDAQ:SIRO). With sales of approximately $14 million, Sirona Direct is the exclusive distributor of dental equipment for Sirona Dental Systems in Paris and Normandy. Henry Schein, Inc. (NASDAQ:HSIC) stock opened today at $118.89 and is currently trading at $119.60. The stock showed a positive weekly performance of 2.48%.
Leave a Reply